FDA Reviewing MDMA as Potential Treatment for PTSD
The Food and Drug Administration (FDA) is set to evaluate MDMA, commonly known as ecstasy or molly, as a prospective treatment for Post-Traumatic Stress Disorder (PTSD). This groundbreaking initiative marks a significant step in exploring alternative therapies for individuals grappling with PTSD, potentially offering new avenues for relief from this debilitating condition. The FDA’s decision … Read more